New data reveals that Januvia was as effective as Glucotrol in reducing blood sugar levels in patients with type 2 diabetes.Merck (NYSE: MRK) announced today its drug Januvia was as effective as the ...

Fact checked by Jennifer Klump Key Takeaways Insulin costs have declined over the past two years, and additional price cuts ...

NEW YORK (Reuters) - Aggressive marketing of Merck & Co.'s new first-in-class diabetes drug Januvia has led to a strong launch, according to data compiled by ImpactRx Inc., a market research company ...

According to the United Nations, the number of people with diabetes has almost quadrupled since 1980, and the prevalence of ...

Resource4thePeople announced today that it providing consumers who are following the progress of lawsuits alleging that a class of diabetes medications including Januvia, Janumet, Byetta and Victoza ...

For many of us, Thursday was Health-Policy-Wonk Festivus. The Centers for Medicare & Medicaid Services released the Maximum Fair Prices (MFPs) for the first 10 drugs subject to negotiation under the ...

LONDON, Aug 3 (Reuters) - AstraZeneca and Bristol-Myers Squibb's new once-daily diabetes drug Onglyza will cost the same as Merck & Co Januvia, setting up a head-to-head battle for U.S. market share.

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...